Core Viewpoint - EZZ Life Science Holdings Limited has been recognized as an outstanding innovative research and development enterprise in the health industry, highlighting its leadership in gene technology and its effective market transformation capabilities [1] Group 1: Company Strategy and Innovation - EZZ is transitioning from a broad health approach to a precision health model, focusing on gene-centered life sciences to address the underlying logic of health management [2] - The company has established a global top-tier research and development network by collaborating with leading institutions such as the New Zealand Gene Research Center and the University of Sydney, creating a comprehensive R&D system from basic research to product implementation [2] - EZZ emphasizes understanding the "code of human health" through gene technology, allowing for personalized health solutions tailored to different regional health characteristics [3] Group 2: Product Development and Market Adaptation - The EZZ Growth Capsule 3.0 targets the critical growth period of adolescents, enhancing nutritional supply and absorption efficiency with a formula that includes 437.3 mg of lysine and a combination of calcium, vitamin K2, and vitamin D3 [6] - The company adapts its products to local market needs, such as controlling sugar and calorie content for Chinese children, and developing easy-to-consume formulations that address common dietary issues [10] - EZZ's collaboration with the University of Sydney marks a significant step in validating the efficacy of its growth series products, transitioning from concept-driven to evidence-based development [8] Group 3: Future Outlook and Industry Trends - EZZ plans to focus on three core technologies in the next one to two years: enhancing nutrient release and bioavailability in cellular health, improving probiotic survival rates, and developing layered encapsulation technology for better nutrient absorption [11] - The recognition of EZZ as a "sunshine" case aligns with the health industry's trends towards precision, scientific, and localized approaches, positioning the company to lead in providing high-quality health solutions across different demographics [13]
2025阳光案例揭晓|EZZ凭基因科技入选创新研发案例锚定全生命周期健康
21世纪经济报道·2025-12-31 07:48